Publicaciones en las que colabora con Antonio Llombart Cussac (6)

2020

  1. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study

    Gynecologic Oncology, Vol. 159, Núm. 3, pp. 721-731

2012

  1. Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541

  2. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978

2008

  1. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells

    Anti-Cancer Drugs, Vol. 19, Núm. 2, pp. 115-124

  2. Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines

    British Journal of Dermatology, Vol. 158, Núm. 3, pp. 496-504

  3. Targeted therapies in gynecologic cancers and melanoma

    Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273